SugaROx has secured £1million in additional funding through fertiliser producer The Mosaic Company and a range of private investors and sustainable investment funds.
Biostimulants are one of the fastest growing crop input sectors, with an estimated 11% compound annual growth rate (CAGR). The funding will allow the company to upscale the development of Trehalose-6-Phosphate (T6P).
T6P boosts the yields and resilience of crops by inhibiting SnRK1, an enzyme that signals energy scarcity in the plant. Safety tests were completed in early 2024, confirming a promising regulatory outlook for the proprietary T6P.
SugaROx is looking to launch its T6P wheat biostimulant in the UK market in 2027 and in the EU in 2028. Earlier this year the company started trials in soybean and maize with a view to enter the US and Brazilian markets shortly after.
Commenting on the additional £1million raised, CEO Mark Robbins, said: “In response to increasing demand for product samples, we decided to accelerate our manufacturing timeline, fast‑tracking the shift from in‑house lab production to a pilot facility. The Innovate UK grant and additional investment allows us to do that.”
Explaining the benefits of Mosaic’s investment, Dr Cara Griffiths co-founder, added: “With Mosaic we gain access to an established network of trial sites for validation of our first product in the US at scale. Mosaic will also provide us with access to TruResponse®, a digital platform to visualise field results, which will be extremely valuable for our research.”
